EXTENDEE RELEASE FORMULATION OF PRAMIPEXOLE

摘要

The present invention relates to stable extended release formulation comprising Pramipexol or a pharmaceutically acceptable salt thereof in a matrix comprising at least one neutral polymer with Dicalcium phosphate and further cxcipients, wherein the resulting extended release formulation provides pH-dependent release characteristics in vitro/in vivo without using anionic polymers.